Pro-inflammatory cytokines and chemokines induced by Cutibacterium acnes

Pro-inflammatory mediators induced by pathogenic Cutibacterium acnes phylotypes refer to a diverse group of signaling proteins, including Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), Interleukin-8 (IL-8), and Tumor Necrosis Factor-alpha (TNF-α), which are secreted by host cells in response to specific strains of the skin bacterium C. acnes (PMID: 30845345). Research has demonstrated that phylotype IA1 is more frequently associated with acne lesions and induces a significantly more robust inflammatory response than commensal phylotypes like type II or III (PMID: 23359452). These mediators are primarily produced when C. acnes triggers Toll-like receptor 2 (TLR2) on keratinocytes and monocytes, subsequently activating the NLRP3 inflammasome pathway (PMID: 24613614). This inflammatory cascade is a central driver of the redness, swelling, and tissue damage observed in acne vulgaris. Therapeutic intervention often involves the use of topical retinoids to downregulate TLR2 expression, antibiotics to reduce bacterial load and cytokine production, or experimental biologics to neutralize specific interleukins (PMID: 29431102). Understanding the differential induction of these mediators by various phylotypes is essential for developing targeted treatments that address the underlying inflammatory pathology of acne.

Other names

C. acnes-induced inflammatory mediatorsAcne-associated cytokinesCutibacterium acnes inflammatory secretomeP. acnes-induced pro-inflammatory mediators

Drugs typically act by reducing the population of pathogenic C. acnes phylotypes, inhibiting the activation of upstream signaling pathways like TLR2 or the NLRP3 inflammasome, or directly neutralizing the resulting cytokines (e.g., IL-1 beta).